Target Name: SRSF6
NCBI ID: G6431
Review Report on SRSF6 Target / Biomarker Content of Review Report on SRSF6 Target / Biomarker
SRSF6
Other Name(s): SRP55 | B52 | SR splicing factor 6 | Splicing factor, arginine/serine-rich 6 | Pre-mRNA-splicing factor SRP55 | SRSF6_HUMAN | pre-mRNA-splicing factor SRP55 | Serine and arginine rich splicing factor 6, transcript variant 1 | serine/arginine-rich splicing factor 6 | SRSF6 variant 1 | Serine/arginine-rich splicing factor 6 | epididymis secretory protein Li 91 | SFRS6 | serine and arginine rich splicing factor 6 | SRP55-1 | HEL-S-91 | splicing factor, arginine/serine-rich, 55 kDa

SRSF6: A Protein Implicated in Tissue Development and Disease

SRSF6 (SRP55) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the SRSF family of proteins, which are known for their role in cell-cell adhesion and tissue organization.

SRSF6 has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these conditions is not well understood, but its involvement in these processes is thought to be important for the development and progression of these diseases.

One of the key functions of SRSF6 is its role in cell-cell adhesion. This is the process by which cells stick together to form tissues and organs. SRSF6 is thought to be involved in the formation of tight junctions, which are the weakest type of cell-cell adhesion.

In neurodegenerative diseases, such as Alzheimer's disease, SRSF6 has been shown to be involved in the development of neurofibrillary tangles and other hallmark pathological changes. The deficiency of SRSF6 may also be related to neurodegenerative diseases.

SRSF6 is also thought to be involved in the development and progression of certain autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis. In these conditions, the immune system attacks the body's own tissues, leading to inflammation and damage. SRSF6 may be a key player in this process, as its absence has been linked to an increased risk of developing these autoimmune disorders.

In addition to its role in cell-cell adhesion, SRSF6 has also been shown to play a role in regulating cell proliferation. This is the process by which cells grow and divide, and is important for the development and maintenance of tissues and organs.

SRSF6 has also been shown to be involved in the regulation of cell migration. This is the process by which cells move from one location to another in the body, and is important for the formation of tissues and organs.

Overall, SRSF6 is a protein that is involved in a wide range of biological processes that are important for the development and maintenance of tissues and organs. Its potential as a drug target or biomarker makes it an attractive target for researchers to study, and its role in neurodegenerative diseases and autoimmune disorders should be further investigated.

Protein Name: Serine And Arginine Rich Splicing Factor 6

Functions: Plays a role in constitutive splicing and modulates the selection of alternative splice sites. Plays a role in the alternative splicing of MAPT/Tau exon 10. Binds to alternative exons of TNC pre-mRNA and promotes the expression of alternatively spliced TNC. Plays a role in wound healing and in the regulation of keratinocyte differentiation and proliferation via its role in alternative splicing

The "SRSF6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SRSF6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SRSF6P1 | SRSF7 | SRSF8 | SRSF9 | SRXN1 | SRY | SS18 | SS18L1 | SS18L2 | SSB | SSBP1 | SSBP2 | SSBP3 | SSBP3-AS1 | SSBP3P2 | SSBP4 | SSC4D | SSC5D | SSH1 | SSH2 | SSH3 | SSMEM1 | SSNA1 | SSPN | SSPOP | SSR1 | SSR1P2 | SSR2 | SSR3 | SSR4 | SSR4P1 | SSRP1 | SST | SSTR1 | SSTR2 | SSTR3 | SSTR4 | SSTR5 | SSTR5-AS1 | SSU72 | SSU72L2 | SSU72P1 | SSU72P8 | SSUH2 | SSX1 | SSX2 | SSX2IP | SSX3 | SSX4 | SSX5 | SSX6P | SSX7 | SSX8P | SSX9P | SSXP10 | SSXP5 | ST13 | ST13P16 | ST13P18 | ST13P20 | ST13P4 | ST13P5 | ST14 | ST18 | ST20 | ST20-AS1 | ST20-MTHFS | ST3GAL1 | ST3GAL2 | ST3GAL3 | ST3GAL3-AS1 | ST3GAL4 | ST3GAL5 | ST3GAL5-AS1 | ST3GAL6 | ST3GAL6-AS1 | ST6GAL1 | ST6GAL2 | ST6GALNAC1 | ST6GALNAC2 | ST6GALNAC3 | ST6GALNAC4 | ST6GALNAC4P1 | ST6GALNAC5 | ST6GALNAC6 | ST7 | ST7-AS1 | ST7-OT3 | ST7-OT4 | ST7L | ST8SIA1 | ST8SIA2 | ST8SIA3 | ST8SIA4 | ST8SIA5 | ST8SIA6 | ST8SIA6-AS1 | STAB1 | STAB2 | STAC